Fewer radiation sessions may keep breast cancer at bay
NCT ID NCT06443359
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a shorter, more intense radiation schedule (hypofractionation) for women with breast cancer who have had surgery. The goal is to see if this approach is safe and effective at preventing cancer from coming back while reducing side effects like arm swelling. Fifty-six women will receive radiation to the breast or chest wall and nearby lymph nodes over about three weeks, and they will be followed for three years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
hypofractionated radiation therapy
What this could lead to
If successful, this could offer a more convenient and equally safe radiation schedule for breast cancer patients, reducing treatment visits and long-term arm swelling.
What could go wrong
This is a small, early-phase study with only 56 participants, so results may not apply to all patients. There is still a risk of cancer recurrence or side effects like lymphedema.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Corewell Health Beaumont Troy Hospital
Troy, Michigan, 48085, United States
-
Corewell Health Dearborn Hospital
Dearborn, Michigan, 48124, United States
-
Corewell Health William Beaumont University Hospital
Royal Oak, Michigan, 48073, United States